- Distal pancreatectomy with splenorenal shunt to preserve spleen in a cirrhotic patient
-
Ettorre GM, Levi Sandri GB, Colasanti , de Werra E, Lepiane P
- KMID: 2379108
- Ann Hepatobiliary Pancreat Surg.
- 2017 May;21(2):93-95.
- doi: 10.14701/ahbps.2017.21.2.93
At pancreatic ductal adenocarcinoma is an aggressive malignancy with a high recurrence rate. Due to its high potentials of local invasion and distant metastasis, surgical resection is the only means... -
- CITED
-
- Close
- SHARE
-
- Close
- Splenic artery steal syndrome after liver transplantation – prophylaxis or treatment?: A case report and literature review
-
Usai S, Colasanti M, Meniconi RL, Ferretti S, Guglielmo N, Mariano G, Berardi G, Cinquepalmi M, Angrisani M, Ettorre GM
- KMID: 2536389
- Ann Hepatobiliary Pancreat Surg.
- 2022 Nov;26(4):386-394.
- doi: 10.14701/ahbps.22-004
Splenic artery steal syndrome (SASS) is a cause of graft hypoperfusion leading to the development of biliary tract complications, graft failure, and in some cases to retransplantation. Its management is... -
- CITED
-
- Close
- SHARE
-
- Close
- Portal vein arterialization following a radical left extended hepatectomy for Klatskin tumor: A case report
-
Basso CD, Meniconi RL, Usai S, Guglielmo N, Colasanti M, Ferretti S, Sandri GBL, Ettorre GM
- KMID: 2519303
- Ann Hepatobiliary Pancreat Surg.
- 2021 Aug;25(3):426-430.
- doi: 10.14701/ahbps.2021.25.3.426
Portal vein arterialization (PVA) has been attracting attention for its role as a salvage inf low technique in various clinical applications. Initially performed in shunt surgery for portal hypertension, with the... -
- CITED
-
- Close
- SHARE
-
- Close
- High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients
-
Pellicelli A, Messina V, Giannelli , Distefano , Palitti VP, Vignally P, Tarquini P, Izzi A, Moretti A, Babudieri , Dell’Isola S, Marignani , Scifo G, Iovinella , Cariti G, Pompili M, Candilo FD, Fontanella L, Ettorre GM, Vennarecci G, Ippolito A, Barbarini
- KMID: 2500540
- Gut Liver.
- 2020 May;14(3):357-367.
- doi: 10.5009/gnl18269
Background/Aims: Patients with genotype 3 hepatitis C virus (G3-HCV) cirrhosis are very difficult to treat compared to patients with other HCV genotypes. The optimal treatment duration and drug regimen associated... -
- CITED
-
- Close
- SHARE
-
- Close
